Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
17.00
-0.43 (-2.47%)
At close: Aug 21, 2026, 4:00 PM EDT
16.75
-0.25 (-1.47%)
After-hours: Aug 21, 2026, 7:42 PM EDT
Mesoblast Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Mesoblast stock have an average target of $35, which predicts a 105.88% increase from the current stock price of 17.
Price Target: $35 (+105.88%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Apr 15, 2026.
Analyst Ratings
The average analyst rating for Mesoblast stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $35 | Buy | Maintains | $35 | +105.88% | Apr 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $35 | Buy | Reiterates | $35 | +105.88% | Apr 10, 2026 |
Financial Forecast
Revenue This Year
117.95M
from 17.20M
Increased by 585.84%
Revenue Next Year
203.57M
from 117.95M
Increased by 72.59%
EPS This Year
-0.04
from -0.07
EPS Next Year
0.03
from -0.04
EPS and Forward PE are based on non-GAAP adjusted numbers.